---
$id: https://graph.org.ai/products/commodity/51433803
$type: Product
source: UNSPSC
code: "51433803"
title: "Cilazaprilat"
class: "51433800"
classTitle: "Antihypertensive pyridazines"
family: "51430000"
familyTitle: "Antihypertensive drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cilazaprilat

**UNSPSC Code**: 51433803
**Class**: [Antihypertensive pyridazines](Antihypertensive pyridazines.mdx)
**Family**: [Antihypertensive drugs](../Antihypertensive drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an ace inhibitor with the molecular formula C20H27N3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WBL76FH528, chemically known as n-((1s,9s)-1-carboxy-10-oxoperhydropyridazino-(1,2-alpha)(1,2)diazepin-9-yl)-4-phenyl-l-homoalanine but generally known as cilazaprilat, which bears US NIH Compound Identifier 64766. European Medicines Agency schedules Cilazaprilat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06266MIG. The term CILAZAPRILAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). CILAZAPRILAT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cilazaprilat under HS 29339940 and SITC 51577. As of Q4 2014, CILAZAPRILAT remains the US FDA Preferred Term for this commodity. Cilazaprilat bears US NLM identifiers UMLS ID C0055724 and NCI Concept Code C75927. SMILES: O=C1N2N(CCCC2C(=O)O)CCCC1NC(CCc1ccccc1)C(=O)O.

